Literature DB >> 33428276

Sex differences in the incidence and mode of death in rats with heart failure with preserved ejection fraction.

Khaled Elkholey1, Lynsie Morris1, Monika Niewiadomska1, Jeremy Houser1, Michelle Ramirez1, Mulan Tang1, Mary Beth Humphrey1, Stavros Stavrakis1.   

Abstract

NEW
FINDINGS: What is the central question of this study? Prior studies failed to address the role of sex in modifying the pathophysiology and response to therapy in heart failure with preserved ejection fraction (HFpEF), potentially introducing bias into translational findings. We aimed to explore sex differences in outcomes and sought to identify the underlying mechanisms in a well-established rat model of HFpEF. What is the main finding and its importance? Male rats with HFpEF exhibited worse survival compared with females and were at a higher risk for sudden death, attributable in part to QT prolongation, autonomic dysregulation and enhanced inflammation. These data might provide the basis for the development of sex-specific interventions in HFpEF targeting these abnormalities. ABSTRACT: Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of heart failure, and sudden death is the leading cause of mortality. We aimed to explore sex differences in outcomes in rats with HFpEF and sought to identify the underlying mechanisms. Dahl salt-sensitive rats of either sex were randomized into high-salt diet (HS diet; 8% NaCl, n = 46, 50% female) or low-salt diet (LS diet; 0.3% NaCl; n = 24, 50% female) at 7 weeks of age. After 6 and 10 weeks of LS or HS diets, the ECG, heart rate variability, cytokines and echocardiographic parameters were measured. The animals were monitored daily for development of HFpEF and survival. Over 6 weeks of HS diet, rats developed significant hypertension and signs of HFpEF. Compared with female HS diet-fed rats, males exhibited more left ventricular dilatation, a longer QT interval, and worse autonomic tone, as assessed by heart rate variability and elevated inflammatory cytokines. Ten of 23 (46%) male rats died during follow-up, compared with two of 23 (9%) female rats (P = 0.01). There were four sudden deaths in males (with ventricular tachycardia documented in one rat), whereas the females died of heart failure. In conclusion, male rats with HFpEF exhibit worse survival compared with females and are at a higher risk for sudden death, attributable in part to QT prolongation, autonomic dysregulation and enhanced inflammation. These data might provide the basis for the development of sex-specific interventions in HFpEF targeting these abnormalities.
© 2021 The Authors. Experimental Physiology © 2021 The Physiological Society.

Entities:  

Keywords:  autonomic tone; heart failure with preserved ejection fraction; sex; sudden death; ventricular arrhythmias

Mesh:

Year:  2021        PMID: 33428276      PMCID: PMC7920931          DOI: 10.1113/EP089163

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  30 in total

1.  Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.

Authors:  Liping Zhou; Adrian Filiberti; Mary Beth Humphrey; Christian D Fleming; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis
Journal:  Exp Physiol       Date:  2018-11-29       Impact factor: 2.969

Review 2.  Mode of Death in Heart Failure With Preserved Ejection Fraction.

Authors:  Muthiah Vaduganathan; Ravi B Patel; Alexander Michel; Sanjiv J Shah; Michele Senni; Mihai Gheorghiade; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2017-02-07       Impact factor: 24.094

3.  Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of TOPCAT Trial.

Authors:  Miranda Merrill; Nancy K Sweitzer; JoAnn Lindenfeld; David P Kao
Journal:  JACC Heart Fail       Date:  2019-03       Impact factor: 12.035

4.  Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial.

Authors:  Michael R Zile; William H Gaasch; Inder S Anand; Markus Haass; William C Little; Alan B Miller; Jose Lopez-Sendon; John R Teerlink; Michel White; John J McMurray; Michel Komajda; Robert McKelvie; Agata Ptaszynska; Scott J Hetzel; Barry M Massie; Peter E Carson
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

5.  Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.

Authors:  Constantijn Franssen; Sophia Chen; Andreas Unger; H Ibrahim Korkmaz; Gilles W De Keulenaer; Carsten Tschöpe; Adelino F Leite-Moreira; René Musters; Hans W M Niessen; Wolfgang A Linke; Walter J Paulus; Nazha Hamdani
Journal:  JACC Heart Fail       Date:  2015-12-09       Impact factor: 12.035

6.  Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.

Authors:  John J V McMurray; Alice M Jackson; Carolyn S P Lam; Margaret M Redfield; Inder S Anand; Junbo Ge; Marty P Lefkowitz; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Adel R Rizkala; Shalini V Sabarwal; Amil M Shah; Sanjiv J Shah; Victor C Shi; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Maja Cikes; Eva Goncalvesova; Tzvetana Katova; Anamaria Kosztin; Malgorzata Lelonek; Nancy Sweitzer; Orly Vardeny; Brian Claggett; Pardeep S Jhund; Scott D Solomon
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

7.  Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.

Authors:  Pooja Dewan; Rasmus Rørth; Valeria Raparelli; Ross T Campbell; Li Shen; Pardeep S Jhund; Mark C Petrie; Inder S Anand; Peter E Carson; Akshay S Desai; Christopher B Granger; Lars Køber; Michel Komajda; Robert S McKelvie; Eileen O'Meara; Marc A Pfeffer; Bertram Pitt; Scott D Solomon; Karl Swedberg; Michael R Zile; John J V McMurray
Journal:  Circ Heart Fail       Date:  2019-12-09       Impact factor: 8.790

Review 8.  Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.

Authors:  Andrea Rodrigues Sabbatini; Georgios Kararigas
Journal:  J Am Coll Cardiol       Date:  2020-03-10       Impact factor: 24.094

9.  Neuroinflammation in heart failure: new insights for an old disease.

Authors:  Hugo S Díaz; Camilo Toledo; David C Andrade; Noah J Marcus; Rodrigo Del Rio
Journal:  J Physiol       Date:  2019-12-03       Impact factor: 5.182

Review 10.  Autonomic Modulation of Cardiac Arrhythmias: Methods to Assess Treatment and Outcomes.

Authors:  Stavros Stavrakis; Kanchan Kulkarni; Jagmeet P Singh; Demosthenes G Katritsis; Antonis A Armoundas
Journal:  JACC Clin Electrophysiol       Date:  2020-05
View more
  4 in total

1.  Transcutaneous Vagus Nerve Stimulation Ameliorates the Phenotype of Heart Failure With Preserved Ejection Fraction Through Its Anti-Inflammatory Effects.

Authors:  Khaled Elkholey; Monika Niewiadomska; Lynsie Morris; Seabrook Whyte; Jeremy Houser; Mary Beth Humphrey; Stavros Stavrakis
Journal:  Circ Heart Fail       Date:  2022-07-07       Impact factor: 10.447

2.  Mechanisms of Sinoatrial Node Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Thassio Mesquita; Rui Zhang; Jae Hyung Cho; Rui Zhang; Yen-Nien Lin; Lizbeth Sanchez; Joshua I Goldhaber; Joseph K Yu; Jialiu A Liang; Weixin Liu; Natalia A Trayanova; Eugenio Cingolani
Journal:  Circulation       Date:  2021-12-14       Impact factor: 39.918

Review 3.  Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models.

Authors:  Coenraad Withaar; Carolyn S P Lam; Gabriele G Schiattarella; Rudolf A de Boer; Laura M G Meems
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 29.983

Review 4.  Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models.

Authors:  Willem B van Ham; Elise L Kessler; Marish I F J Oerlemans; M Louis Handoko; Joost P G Sluijter; Toon A B van Veen; Hester M den Ruijter; Saskia C A de Jager
Journal:  JACC Basic Transl Sci       Date:  2022-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.